Nkarta, Inc. (NKTX) - Latest Market Data

Price & Market Data

Price: $3.02

Daily Change: -$0.009 / 0.30%

Daily Range: $3.01 - $3.25

Market Cap: $216,782,432

Daily Volume: 357,114

Performance Metrics

1 Week: 7.80%

1 Month: -10.32%

3 Months: 30.47%

6 Months: 76.74%

1 Year: 78.82%

YTD: 62.57%

About Nkarta, Inc. (NKTX)

A financial summary of Nkarta, Inc. (NKTX). Price: 3.02, daily change: -$0.009 / 0.30%. Market cap: 216,782,432. Performance from 3-month to 1-year.

Company Details

Employees: 108

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. Its lead product candidate is NKX019, a chimeric antigen receptor-natural killer (CAR NK) targeting the CD19 antigen, which is in Phase 1 clinical trial for the treatment of lupus nephritis; systemic sclerosis; idiopathic inflammatory myopathy; and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, as well as for systemic lupus erythematosus and myasthenia gravis. The company has a research collaboration agreement with CRISPR Therapeutics AG. Nkarta, Inc. was incorporated in 2015 and is based in South San Francisco, California.

Selected stocks

Heartbeam, Inc. (BEAT)

FatPipe, Inc. (FATN)

DouYu International Holdings Limited (DOYU)

Rafael Holdings, Inc. (RFL)